Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 825 results for "eli lilly"

New Drug to Fight Alzheimer's Disease Soon from AstraZeneca, Eli Lilly Combo
Med India

Eli Lilly's Trulicity receives US FDA approval to treat adults...

Eli Lilly and Company announced that the approval of Trulicity (dulaglutide) by the US Food and Drug Administration is the latest treatment option for adults with type 2 diabetes. Trulicity is indicated as an adjunct to diet and exercise to ... PharmaBiz, 1 hour ago
[x]  

79 images for eli lilly

American Banking News, 1 day ago
Med India, 2 days ago
Mideast Time, 1 week ago
I Stock Analyst, 1 week ago
4 Traders, 2 weeks ago
Drug Discovery and Development, 17 hours ago
Digital Look, 18 minutes ago
Jutia Group, 3 weeks ago
Jutia Group, 3 weeks ago
FiercePharma, 5 days ago

Boehringer and Lilly announce encouraging results from Phase III diabetes study

Boehringer Ingelheim and Eli Lilly and Company have announced results from a 52-week Phase III study that demonstrated sustained efficacy of the investigational empagliflozin/linagliptin combination tablet in adults with type 2 diabetes, or T2D, ...
 Individual.com18 hours ago Eli Lilly's Phase III metastatic colorectal cancer study meets primary endpoint  Individual.com2 days ago Eli Lilly's Cyramza Scores in Colorectal Cancer Study  Yahoo! Finance4 days ago
[x]  

Eli Lilly's Trulicity Approved by FDA for Type II Diabetes

Eli Lilly and Company ( LLY ) received good news when the FDA approved its new injectable diabetes treatment, Trulicity, for adults suffering from type II diabetes. Trulicity, a glucagon-like peptide-1 (GLP-1) receptor, has been approved as an ...
 Yahoo! Finance12 hours ago
[x]  

Watch for Shares of Eli Lilly (LLY) to Approach Resistance at $67.05

Shares of Eli Lilly (NYSE:LLY) opened today above their pivot of $66.43 and have already reached the first level of resistance at $66.82. Analysts will be watching for a cross of the next upside pivot targets of $67.05
 Individual.com17 hours ago

Dow and Elanco join forces to increase meat and milk production

GREENFIELD, IND. AND INDIANAPOLIS Two Indiana agricultural companies, Elanco, the animal health division of Eli Lilly and Company (NYSE: LLY), and Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), are ...
 Dairy Herd18 hours ago Stock Update (NYSE:LLY): Elanco Animal Health, Dow AgroSciences Announce Strategic R&D Agreement  Crawford Financial Planning1 day ago Dow AgroSciences, Elanco Announce Joint R & D Agreement  Agri Marketing1 day ago Elanco, Dow AgroSciences announce strategic agreement  Progressive Dairy11 hours ago
[x]  

SmarTrend Watching for Potential Pullback in Shares of Eli Lilly After 1.03% Gain

Eli Lilly (NYSE:LLY) traded in a range yesterday that spanned from a low of $66.04 to a high of $66.66. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $66.18 on volume of 4.0 million shares. Often times ...
 Individual.com1 day ago Look for Shares of Eli Lilly to Potentially Pullback after Yesterday's 1.03% Rise  Individual.com1 day ago

Lilly's Phase III Trial Of Cyramza With Paclitaxel Meets Endpoints

Eli Lilly and Co. (LLY: Quote) Thursday said its Phase III trial of ramucirumab or Cyramza in combination with paclitaxel in patients with advanced gastric cancer or gastroesophageal junction adenocarcinoma met primary and secondary endpoints.
 RTTNews.com1 day ago Eli Lilly and Company Release: CYRAMZA??? In Combination With Paclitaxel Significantly Improves Overall Survival In Second-Line Gastric Cancer Patients  BioSpace1 day ago Eli Lilly : CYRAMZA In Combination With Paclitaxel Significantly Improves Overall Survival In Second-Line Gastric Cancer Patients  4 Traders1 day ago Ramucirumab/Paclitaxel Improves Survival in Second-Line Gastric Cancer Patients  PT Community1 day ago

AbbVie, Eli Lilly, Auxilium Might See Decline In Revenue From Testosterone Therapies

Manufacturers of testosterone products, like AbbVie, Eli Lilly, Endo International, and Auxilium, might witness a decline in their US retail prescriptions due to suggestions of label restrictions by advisory committees Page 1 of 3 Click ...
 Bidness Etc1 day ago

AstraZeneca, Lilly To Jointly Develop AZD3293 For Alzheimer's Disease - Update

British drug maker AstraZeneca (AZN.L,AZN: Quote) Tuesday announced an agreement with its U.S. peer Eli Lilly and Co. (LLY: Quote) to jointly develop and commercialise BACE Inhibitor AZD3293, which is currently in development as a potential ...
 RTTNews.com4 days ago AstraZeneca, Lilly Reach Deal On BACE Inhibitor AZD3293 For Alzheimer's Disease  RTTNews.com4 days ago

Eli Lilly v Human Genome Sciences Ltd

UK High Court denies Eli Lilly's request to prevent Human Genome Sciences Ltd from obtaining a Supplementary Protection Certificate for the human monoclonal antibody, tabalumab. Summary In a judgment dated 18 July 20141, the UK High Court refused ...
 Lexology2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - eli lilly
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less